1
|
Siegel R, Ward E, Brawley O and Jemal A:
Cancer statistics, 2011: The impact of eliminating socioeconomic
and racial disparities on premature cancer deaths. CA Cancer J
Clin. 61:212–236. 2011. View Article : Google Scholar : PubMed/NCBI
|
2
|
Ma J, Siegel R and Jemal A: Pancreatic
cancer death rates by race among US men and women, 1970–2009. J
Natl Cancer Inst. 105:1694–1700. 2013. View Article : Google Scholar : PubMed/NCBI
|
3
|
Li D, Xie K, Wolff R and Abbruzzese JL:
Pancreatic cancer. Lancet. 363:1049–1057. 2004. View Article : Google Scholar : PubMed/NCBI
|
4
|
Jemal A, Siegel R, Ward E, Hao Y, Xu J,
Murray T and Thun MJ: Cancer statistics, 2008. CA Cancer J Clin.
58:71–96. 2008. View Article : Google Scholar : PubMed/NCBI
|
5
|
Rozenblum E, Schutte M and Goggins M:
Tumor-suppressive pathways in pancreatic carcinoma. Cancer Res.
57:1731–1734. 1997.PubMed/NCBI
|
6
|
Luo J, Guo P and Matsuda K: Pancreatic
cancer cell-derived vascular endothelial growth factor is
biologically active in vitro and enhances tumorigenicity in vivo.
Int J Cancer. 92:361–369. 2001. View
Article : Google Scholar : PubMed/NCBI
|
7
|
Xie K: Interleukin-8 and human cancer
biology. Cytokine Growth Factor Rev. 12:375–391. 2001. View Article : Google Scholar : PubMed/NCBI
|
8
|
Yamanaka Y, Friess H and Buchler M:
Overexpression of acidic and basic fibroblast growth factors in
human pancreatic cancer correlates with advanced tumor stage.
Cancer Res. 53:5289–5296. 1993.PubMed/NCBI
|
9
|
Ponting CP, Oliver PL and Reik W:
Evolution and functions of long noncoding RNAs. Cell. 136:629–641.
2009. View Article : Google Scholar : PubMed/NCBI
|
10
|
Wilusz JE, Sunwoo H and Spector DL: Long
noncoding RNAs: Functional surprises from the RNA world. Genes Dev.
23:1494–1504. 2009. View Article : Google Scholar : PubMed/NCBI
|
11
|
Grandér D and Johnsson P:
Pseudogene-expressed RNAs: Emerging roles in gene regulation and
disease. Curr Top Microbiol Immunol. 2015.
|
12
|
Welch JD, Baran-Gale J, Perou CM,
Sethupathy P and Prins JF: Pseudogenes transcribed in breast
invasive carcinoma show subtype-specific expression and ceRNA
potential. BMC Genomics. 16:1–16. 2015. View Article : Google Scholar : PubMed/NCBI
|
13
|
Poliseno L, Salmena L, Zhang J, Carver B,
Haveman WJ and Pandolfi PP: A coding-independent function of gene
and pseudogene mRNAs regulates tumour biology. Nature.
465:1033–1038. 2010. View Article : Google Scholar : PubMed/NCBI
|
14
|
Hayashi H, Arao T, Togashi Y, Kato H,
Fujita Y, De Velasco MA, Kimura H, Matsumoto K, Tanaka K, Okamoto
I, et al: The OCT4 pseudogene POU5F1B is amplified and promotes an
aggressive phenotype in gastric cancer. Oncogene. 34:199–208. 2015.
View Article : Google Scholar : PubMed/NCBI
|
15
|
Vanaja DK, Cheville JC, Iturria SJ and
Young CY: Transcriptional silencing of zinc finger protein 185
identified by expression profiling is associated with prostate
cancer progression. Cancer Res. 63:3877–3882. 2003.PubMed/NCBI
|
16
|
Kiem HP, Ironside C, Beard BC and
Trobridge GD: A retroviral vector common integration site between
leupaxin and zinc finger protein 91 (ZFP91) observed in baboon
hematopoietic repopulating cells. Exp Hematol. 38:819–822. 2010.
View Article : Google Scholar : PubMed/NCBI
|
17
|
Unoki M, Okutsu J and Nakamura Y:
Identification of a novel human gene, ZFP91, involved in acute
myelogenous leukemia. Int J Oncol. 22:1217–1223. 2003.PubMed/NCBI
|
18
|
Al Dulaimi D: Recent advances in gastric
cancer. Gastroenterol Hepatol Bed Bench. 7:238–240. 2014.PubMed/NCBI
|
19
|
Kim DH, Behlke MA, Rose SD, Chang MS, Choi
S and Rossi JJ: Synthetic dsRNA Dicer substrates enhance RNAi
potency and efficacy. Nat Biotechnol. 23:222–226. 2005. View Article : Google Scholar : PubMed/NCBI
|
20
|
Guo W, Zhang Y, Chen T, Wang Y, Xue J,
Zhang Y, Xiao W, Mo X and Lu Y: Efficacy of RNAi targeting of
pyruvate kinase M2 combined with cisplatin in a lung cancer model.
J Cancer Res Clin Oncol. 137:65–72. 2011. View Article : Google Scholar : PubMed/NCBI
|
21
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2 (−Delta Delta C (T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
22
|
Liang CC, Park AY and Guan JL: In vitro
scratch assay: A convenient and inexpensive method for analysis of
cell migration in vitro. Nat Protoc. 2:329–333. 2007. View Article : Google Scholar : PubMed/NCBI
|
23
|
Shain AH, Giacomini CP, Matsukuma K,
Karikari CA, Bashyam MD, Hidalgo M, Maitra A and Pollack JR:
Convergent structural alterations define SWItch/Sucrose
NonFermentable (SWI/SNF) chromatin remodeler as a central tumor
suppressive complex in pancreatic cancer. Proc Natl Acad Sci USA.
109:E252–E259. 2012. View Article : Google Scholar : PubMed/NCBI
|
24
|
Jones S, Zhang X, Parsons DW, Lin JC,
Leary RJ, Angenendt P, Mankoo P, Carter H, Kamiyama H, Jimeno A, et
al: Core signaling pathways in human pancreatic cancers revealed by
global genomic analyses. Science. 321:1801–1806. 2008. View Article : Google Scholar : PubMed/NCBI
|
25
|
Efthimiou E, Crnogorac-Jurcevic T, Lemoine
NR and Brentnall TA: Inherited predisposition to pancreatic cancer.
Gut. 48:143–147. 2001. View Article : Google Scholar : PubMed/NCBI
|
26
|
Chang H: RNAi-mediated knockdown of target
genes: A promising strategy for pancreatic cancer research. Cancer
Gene Ther. 14:677–685. 2007. View Article : Google Scholar : PubMed/NCBI
|
27
|
Gartel AL and Kandel ES: RNA interference
in cancer. Biomol Eng. 23:17–34. 2006. View Article : Google Scholar : PubMed/NCBI
|
28
|
Gleich LL: Gene therapy for head and neck
cancer. Laryngoscope. 110:708–726. 2000. View Article : Google Scholar : PubMed/NCBI
|
29
|
Paschke L, Rucinski M, Ziolkowska A,
Zemleduch T, Malendowicz W, Kwias Z and Malendowicz LK: ZFP91-a
newly described gene potentially involved in prostate pathology.
Pathol Oncol Res. 20:453–459. 2014. View Article : Google Scholar : PubMed/NCBI
|
30
|
Zeisberg M, Hanai J, Sugimoto H, Mammoto
T, Charytan D, Strutz F and Kalluri R: BMP-7 counteracts
TGF-beta1-induced epithelial-to-mesenchymal transition and reverses
chronic renal injury. Nat Med. 9:964–968. 2003. View Article : Google Scholar : PubMed/NCBI
|
31
|
Thiery JP: Epithelial-mesenchymal
transitions in tumour progression. Nat Rev Cancer. 2:442–454. 2002.
View Article : Google Scholar : PubMed/NCBI
|
32
|
Thiery JP, Acloque H, Huang RY and Nieto
MA: Epithelial-mesenchymal transitions in development and disease.
Cell. 139:871–890. 2009. View Article : Google Scholar : PubMed/NCBI
|
33
|
Kurahara H, Takao S, Maemura K, Mataki Y,
Kuwahata T, Maeda K, Ding Q, Sakoda M, Iino S, Ishigami S, et al:
Epithelial-mesenchymal transition and mesenchymal-epithelial
transition via regulation of ZEB-1 and ZEB-2 expression in
pancreatic cancer. J Surg Oncol. 105:655–661. 2012. View Article : Google Scholar : PubMed/NCBI
|
34
|
Hotz B, Arndt M, Dullat S, Bhargava S,
Buhr HJ and Hotz HG: Epithelial to mesenchymal transition:
Expression of the regulators snail, slug, and twist in pancreatic
cancer. Clin Cancer Res. 13:4769–4776. 2007. View Article : Google Scholar : PubMed/NCBI
|
35
|
Wang YL, Dong FL, Yang J, Li Z, Zhi QM,
Zhao X, Yang Y, Li DC, Shen XC and Zhou J: Suppression of the
epidermal growth factor-like domain 7 and inhibition of migration
and epithelial-mesenchymal transition in human pancreatic cancer
PANC-1 cells. Asian Pac J Cancer Prev. 16:4065–4069. 2015.
View Article : Google Scholar : PubMed/NCBI
|
36
|
Satelli A and Li S: Vimentin in cancer and
its potential as a molecular target for cancer therapy. Cell Mol
Life Sci. 68:3033–3046. 2011. View Article : Google Scholar : PubMed/NCBI
|
37
|
Murtaugh LC, Law AC, Dor Y and Melton DA:
Beta-catenin is essential for pancreatic acinar but not islet
development. Development. 132:4663–4674. 2005. View Article : Google Scholar : PubMed/NCBI
|
38
|
Wells JM, Esni F, Boivin GP, Aronow BJ,
Stuart W, Combs C, Sklenka A, Leach SD and Lowy AM:
Wnt/beta-catenin signaling is required for development of the
exocrine pancreas. BMC Dev Biol. 7:42007. View Article : Google Scholar : PubMed/NCBI
|
39
|
Hochedlinger K, Yamada Y, Beard C and
Jaenisch R: Ectopic expression of Oct-4 blocks progenitor-cell
differentiation and causes dysplasia in epithelial tissues. Cell.
121:465–477. 2005. View Article : Google Scholar : PubMed/NCBI
|
40
|
Heiser PW, Cano DA, Landsman L, Kim GE,
Kench JG, Klimstra DS, Taketo MM, Biankin AV and Hebrok M:
Stabilization of beta-catenin induces pancreas tumor formation.
Gastroenterology. 135:1288–1300. 2008. View Article : Google Scholar : PubMed/NCBI
|